Page last updated: 2024-08-16

ag 1879 and 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide

ag 1879 has been researched along with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hajduk, PJ; Johnson, EF; Kifle, L; Merta, PJ; Metz, JT; Soni, NB1
Fändrich, F; Gieseler, F; Groth, S; Sebens, S; Ungefroren, H1

Other Studies

2 other study(ies) available for ag 1879 and 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1h-imidazol-2-yl)benzamide

ArticleYear
Navigating the kinome.
    Nature chemical biology, 2011, Volume: 7, Issue:4

    Topics: Drug Design; Pharmacogenetics; Protein Kinases; Proteome; Systems Biology

2011
The Src family kinase inhibitors PP2 and PP1 block TGF-beta1-mediated cellular responses by direct and differential inhibition of type I and type II TGF-beta receptors.
    Current cancer drug targets, 2011, Volume: 11, Issue:4

    Topics: Benzamides; Cadherins; Cell Growth Processes; Cell Line; Cell Line, Tumor; Dioxoles; Epithelial-Mesenchymal Transition; Humans; Indoles; p38 Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Pyrazoles; Pyrimidines; Receptor, Transforming Growth Factor-beta Type I; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Smad2 Protein; Snail Family Transcription Factors; src-Family Kinases; Sulfonamides; Transcription Factors; Transforming Growth Factor beta1

2011